Biocon, Viatris application for Insulin Aspart rejected by USFDA Ruchika Sharma11 Jan 2022 3:30 PM ISTNew Delhi: Biocon Biologics, a subsidiary of biotechnology major Biocon, on Friday said the US health regulator has not approved an application for...
Biocon Biologics partner Viatris wins US court decision on 5 Sanofi Lantus SoloSTAR device patents Ruchika Sharma31 Dec 2021 5:12 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that the U.S. Court of Appeals for the Federal Circuit (USCAFC) has ...
Biocon Biologics, Viatris to offer Insulin Glargine by Walgreens Prescription Savings Club Ruchika Sharma20 Nov 2021 2:14 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. have confirmed that Insulin Glargine (insulin glargine-yfgn)...
Biocon Biologics, Viatris launch interchangeable biosimilars Semglee, Insulin Glargine injections in US Ruchika Sharma17 Nov 2021 11:30 AM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. today announced the U.S. launch of interchangeable biosimilars SEMGLEE...
Biocon Biologics, Viatris interchangeable biosimilar Insulin Glargine preferred on Express Scripts' largest formulary in US Ruchika Sharma21 Oct 2021 3:28 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd. has recently announced that Express Scripts, a pharmacy benefit management...
Biocon Biologics, Viatris get USFDA nod for first interchangeable biosimilar Semglee for diabetes Ruchika Sharma29 July 2021 1:33 PM ISTThe interchangeable Semglee product, which will allow substitution of Semglee for the reference product, Lantus, at the pharmacy counter, will be...
EpiPen Antitrust Case: Sanofi likely to take Mylan to court again Medical Dialogues Team14 Jun 2021 6:12 PM ISTNew Delhi: Challenging the district court's erroneous ruling in a case against pharmaceutical giant Mylan, Sanofi, the French multinational...
Biocon Biologics, Viatris get EC approval for Abevmy Ruchika Sharma26 April 2021 3:29 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed...
Biocon Biologics, Viatris get CHMP nod for Abevmy Ruchika Sharma1 March 2021 1:44 PM ISTBengaluru: Biocon Biologics, a subsidiary of Biocon announced today that the European Medicines Agency's Committee for Medicinal Products for Human...
Biocon Biologics, Viatris get EC nod to Biosimilar Insulin Aspart Kixelle Ruchika Sharma12 Feb 2021 3:43 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that Kixelle, a biosimilar Insulin Aspart co-developed with Viatris...
USFDA informs Biocon Biologics, Mylan about biosimilar Avastin deferred action Ruchika Sharma26 Dec 2020 11:52 AM ISTNew Delhi: Biotechnology major Biocon on Friday said its arm, Biocon Biologics, and Mylan have been informed by the US health regulator of a deferred...
Mylan Wins Summary Judgment against Sanofi in EpiPen Litigation Ruchika Sharma21 Dec 2020 1:26 PM IST"Viatris is extremely pleased with this significant action by the Court as it rejects Sanofi Inc's baseless attempts to argue that Mylan used...
